Publikationen, an denen er mitarbeitet Andrés Íñiguez Romo (13)

2022

  1. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2021

  1. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

    The Lancet, Vol. 397, Núm. 10270, pp. 199-207

  2. Percutaneous and surgical aortic valve replacement. Impact of volume and type of center on results

    REC: Interventional Cardiology, Vol. 3, Núm. 2, pp. 103-111

  3. Reemplazo valvular aórtico percutáneo y quirúrgico.: Influencia del volumen y del tipo de centro tratante en los resultados

    REC: Interventional Cardiology, Vol. 3, Núm. 2, pp. 103-111

  4. TAVI en la curva de aprendizaje en España. Resultados intrahospitalarios comparados con la sustitución valvular aórtica

    REC: CardioClinics, Vol. 56, Núm. 4, pp. 242-249

  5. TAVI in the learning curve in Spain. In-hospital results compared with aortic valve replacement

    REC: CardioClinics, Vol. 56, Núm. 4, pp. 242-249

2020

  1. Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries

    American Heart Journal, Vol. 220, pp. 108-115

  2. Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries

    American Journal of Cardiovascular Drugs, Vol. 20, Núm. 3, pp. 259-269

  3. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction

    Revista espanola de cardiologia (English ed.), Vol. 73, Núm. 2, pp. 114-122

  4. Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention

    European Heart Journal: Acute Cardiovascular Care, Vol. 9, Núm. 7, pp. 764-770

  5. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

    European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42

2019

  1. Long-term impact of diabetes in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION randomized trial

    Catheterization and Cardiovascular Interventions, Vol. 94, Núm. 7, pp. 917-925

2018

  1. Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score

    International Journal of Cardiology, Vol. 254, pp. 10-15